Table 3.
Internal consistency reliability coefficients (Cronbach's alpha).
PF | RP | BP | GH | EV | SF | RE | MH | |
all survivors | 0.95 | 0.91 | 0.87 | 0.87 | 0.87 | 0.79 | 0.86 | 0.84 |
Cancer Diagnosis | ||||||||
leukaemia | 0.94 | 0.90 | 0.87 | 0.87 | 0.86 | 0.73 | 0.84 | 0.82 |
Hodgkin's disease | 0.93 | 0.90 | 0.84 | 0.84 | 0.88 | 0.85 | 0.85 | 0.86 |
non-Hodgkin's | 0.94 | 0.90 | 0.86 | 0.87 | 0.89 | 0.80 | 0.84 | 0.85 |
CNS | 0.96 | 0.91 | 0.88 | 0.88 | 0.86 | 0.78 | 0.88 | 0.92 |
neuroblastoma | 0.95 | 0.91 | 0.88 | 0.87 | 0.87 | 0.76 | 0.83 | 0.85 |
retinoblastoma | 0.95 | 0.89 | 0.85 | 0.85 | 0.87 | 0.75 | 0.84 | 0.86 |
Wilms' tumour | 0.93 | 0.90 | 0.86 | 0.87 | 0.87 | 0.81 | 0.86 | 0.85 |
bone tumour | 0.93 | 0.91 | 0.89 | 0.85 | 0.88 | 0.83 | 0.91 | 0.85 |
soft tissue sarcoma | 0.94 | 0.89 | 0.86 | 0.87 | 0.88 | 0.82 | 0.86 | 0.86 |
other | 0.94 | 0.92 | 0.84 | 0.87 | 0.88 | 0.81 | 0.83 | 0.85 |
Sex | ||||||||
Males | 0.95 | 0.90 | 0.85 | 0.86 | 0.87 | 0.78 | 0.85 | 0.83 |
Females | 0.95 | 0.91 | 0.88 | 0.88 | 0.87 | 0.79 | 0.86 | 0.84 |
Age* | ||||||||
16–19 | 0.95 | 0.86 | 0.82 | 0.85 | 0.85 | 0.72 | 0.82 | 0.81 |
20–29 | 0.95 | 0.90 | 0.85 | 0.87 | 0.87 | 0.78 | 0.85 | 0.84 |
30–39 | 0.95 | 0.91 | 0.88 | 0.87 | 0.88 | 0.81 | 0.86 | 0.85 |
40–49 | 0.96 | 0.93 | 0.88 | 0.88 | 0.88 | 0.82 | 0.88 | 0.84 |
50+ | 0.95 | 0.93 | 0.89 | 0.87 | 0.86 | 0.80 | 0.90 | 0.82 |
Age at diagnosis | ||||||||
0–3 | 0.95 | 0.90 | 0.86 | 0.87 | 0.87 | 0.77 | 0.85 | 0.83 |
4–7 | 0.95 | 0.90 | 0.87 | 0.87 | 0.86 | 0.76 | 0.85 | 0.84 |
8–11 | 0.95 | 0.91 | 0.87 | 0.87 | 0.88 | 0.81 | 0.87 | 0.84 |
12–16 | 0.95 | 0.92 | 0.87 | 0.87 | 0.88 | 0.82 | 0.87 | 0.85 |
*Age at questionnaire completion
PF: Physical Functioning; RP: Role-Limitation Physical; BP; Bodily Pain;
GH: General Health Perception; EV: Energy/Vitality; SF: Social Functioning;
RE: Role-Limitation Emotional: MH: Mental Health